These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Results of combined multicycle locoregional therapy in the palliative treatment of multiple liver metastases].
    Author: Kónya A, Vigváry Z.
    Journal: Orv Hetil; 1995 Jan 15; 136(3):135-40. PubMed ID: 7532843.
    Abstract:
    Twenty eight patients with multiple liver metastases were treated by locoregional intraarterial chemotherapy including 118 (3-7, mean 4.2) cycles. In the majority of patients the treatments were carried out in the form of combined cytostatic infusions into the hepatic artery using 5-FU, doxorubicin, cisplatin and mitomycin-C and were complemented by transcatheter embolisation, chemoembolisation and lipiodolisation. In some patients the lipiodolisation was choosen as the primary treatment. In patients with metastases from breast cancer (n = 11) 3 CR, 6 PR, 2 MR occured, the mean survival was 18.4 months, while the one- and two-year survival was 7/11 and 4/11, respectively. In the colorectal group (n = 10) 0 CR, 6 PR, 4 MR were achieved with a mean survival of 13.6 months; one-year survival was 5/10. In the third group (n = 7) consisting of also patients with the poorest prognosis a mean survival of 11.5 months (referring to 6/7 patients) could be accomplished. A patient with metastases from a retroperitoneal anaplastic carcinoma is still alive and disease-free for 92 months. Authors emphasise the importance and effectiveness of locoregional treatments in improving the quality of life as well as survival of patients with unresectable liver metastases.
    [Abstract] [Full Text] [Related] [New Search]